Aetiology and management of children with acute fever of unknown origin

Paediatric Drugs

Volumn 3, Issue 3, 2001, Pages 169-193

  Akpede, George O ^a   Akenzua, Gregory I ^b  

^a AMBROSE ALLI UNIVERSITY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; AZTREONAM; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; NAFCILLIN; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ACUTE DISEASE; ADVERSE DRUG REACTION; AGE; BACTEREMIA; CHRONIC DISEASE; DISEASE DURATION; DRUG INDICATION; FEBRILE CONVULSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; MENINGITIS; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; REVIEW; RISK FACTOR; SCREENING TEST; SOCIOECONOMICS; TREATMENT INDICATION; TREATMENT PLANNING; URINARY TRACT INFECTION;

EID: 0035078826     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103030-00002     Document Type: Review

References (194)

1. Pathophysiologic basis for symptomatic treatment of fever
2. Fever in childhood: A practising paediatrician's point of view
3. Prolonged fever in children: Review of 100 cases
4. Classification of acute febrile illnesses in childhood
5. Fever without a focus
6. Chills and fever
7. Fever without apparent source on clinical examination, lower respiratory infections in children, bacterial infections, and acute gastroenteritis and diarrhea of infancy and early childhood
8. Fever of unknown origin in the 1980s: An update of the diagnostic spectrum
9. Fever of unknown origin
10. Usefulness of scanning procedures for diagnosis of fever of unknown origin in children
11. Fever of undetermined origin (FUO)
12. Prolonged fever of unknown origin in children
13. Fever of unknown origin
14. Prolonged fever of unknown origin: A record of experiences with 54 childhood patients
15. Prolonged fevers of unknown origin in children: Patterns of presentation and outcome
16. Childhood hyperpyrexia in Benin City, Nigeria
17. Approach to the febrile patient with no obvious focus of infection
18. Aseptic meningitis in infants younger than 2 years of age: Acute illness and neurologic complications
19. Evaluation of the febrile neonate
20. Postviral neurologic syndromes
21. Measles and the central nervous system
22. Aseptic meningitis
23. Severe and complicated malaria
24. Estimating mortality, morbidity and disability due to malaria among Africa's nonpregnant population
25. Malaria with bacteraemia in acutely febrile children without localising signs: Coincidence or association/complication?
26. The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration
27. Impairment of the immune response to vaccination after acute malaria
28. Perspectives on occult bacteremia in children
29. Unsuspected bacteremia in young children: A common and important problem
30. Bacteremia in 28 ambulatory children: Relationship to pneumonitis and meningitis
31. Blood cultures in pediatric practice
32. Antibiotic therapy in febrile children: 'Best-laid schemes'
33. Changing pattern of neonatal septicaemia in an African city
34. Antibiotic resistance among bacterial isolates in neonatal septicaemia
35. Neonatal septicaemia in Benin City, Nigeria
36. Occult pneumococcal bacteremia and the febrile infant and young child: A clinical review
37. Complications of occult pneumococcal bacteremia in children
38. Unsuspected bacteremia due to Haemophilus influenzae: Outcome in children not initially admitted to hospital
39. Risk factors for development of bacterial meningitis among children with occult bacteremia
40. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia
41. Meningitis after lumbar puncture in children with bacteremia
42. Relationship between the magnitude of bacteremia in children and the clinical disease
43. Management of the young febrile child: A commentary on recent practice guidelines
44. Prolonged undiagnosed fever in northern India
45. Fever phobia: The physician's contribution
46. Antipyretic therapy in the febrile child
47. Editorial. Management of childhood fever
48. Febrile status epilepticus
49. Febrile convulsions in Ibadan children
50. Role of viruses in febrile convulsions
51. Pattern of infections in children under-six years old presenting with convulsions associated with fever of acute onset in a children's emergency room in Benin City, Nigeria
52. Occult pneumococcal bacteraemia and febrile convulsions
53. Occult bacteremia in children with simple febrile seizures
54. The best medicine for febrile seizures
55. Outcome of childhood status epilepticus and lengthy febrile convulsions: Findings of national cohort study
56. Risk factors for a first febrile seizure: A matched case-control study
57. A prospective study of recurrent febrile seizures
58. A meta-analytic review of the preventive treatment of recurrences of febrile seizures
59. Factors prognostic of unprovoked seizures after febrile convulsions
60. The first febrile seizure - Antipyretic instruction plus either phenobarbital or placebo to prevent recurrence
61. Febrile seizures: Which to treat and how
62. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures
63. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures
64. Risk factors for seizure recurrence in children with febrile seizures: A pooled analysis of individual patient data from five studies
65. Fever revisited
66. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria
67. Fever
68. Management of feverish children at home
69. Paracetamol: Use in children
70. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children
71. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis
72. Dexamethasone therapy for bacterial meningitis in children
73. Diagnosis and management of meningitis
74. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone
75. Host defences in the neonate: Prospects for enhancement
76. Immunologic basis for increased susceptibility of the neonate to infection
77. Clinical experience of infections in the early years
78. Editorial. Antibiotic therapy in neonatal septicaemia
79. Antibiotic administration to treat possible occult bacteremia in febrile children
80. Community-acquired bacteraemia in African children
81. Bacteremia and bacterial infections in highly febrile children without apparent focus
82. Acute fevers of unknown origin in young children in the tropics
83. Value of serum C-reactive protein concentrations in febrile children without apparent focus
84. Septicaemia in the tropics: A prospective epidemiological study of 146 patients with a high case fatality rate
85. Trends in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: Experience at the University of Maiduguri Teaching Hospital, Nigeria, 1991-1994
86. Bacteremia in hospitalised Black South African children
87. Bacteraemia in febrile Malawian children: Clinical and microbiologic features
88. Bacteremia in sickle hemoglobinopathies
89. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease
90. Bacteraemia in severely malnourished children
91. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection
92. Bacteraemia in Blantyre
93. Paediatric hospital admissions at a South African urban regional hospital: The impact of HIV, 1992-1997
94. Pneumococcal bacteraemia during a decade in children in Soweto, South Africa
95. Management of fever in patients with cancer and treatment-induced neutropenia
96. Tuberculosis recurrence in Africa: True relapse or re-infection?
97. Plasmodium falciparum malaria and perinatally acquired immunodeficiency virus type 1 infection in Kinshasa, Zaire
98. Role of bone marrow examination in the child with prolonged fever
99. Molecular pathology: Diagnosis of infectious diseases
100. Management of the young febrile child: A continuing controversy
101. Infants with fever
102. Evaluation of positive blood cultures: Guidelines for early differentiation of contaminated from valid positive cultures
103. Clinical and cost-effectiveness of outpatient strategies for management of febrile infants
104. Diagnostic value of bone marrow culture in typhoid fever
105. Early diagnosis of neonatal bacteremia by buffycoat examination
106. Rapid identification of the invading microorganism
107. Value of examining buffy coats for intragranulocytic micro-organisms in patients with fever
108. Early diagnosis of bacteremia by buffy-coat examination
109. Early diagnosis of bacteraemia by peripheral blood smears in critically ill newborns
110. Evaluation of buffy-coat microscopy for the early diagnosis of bacteremia
111. Rapid diagnosis of neonatal bacteremia with acridine orange-stained buffy coat smears
112. The use of molecular methods in infectious diseases
113. Cat scratch disease
114. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source
115. Making a presumptive diagnosis of urinary tract infection by using a urinalysis performed in an on-site laboratory
116. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever
117. Evolving concepts in the evaluation of the child with a urinary tract infection
118. Bacterial meningitis beyond the neonatal period
119. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source
120. Lack of impact of guidelines on management of febrile children
121. A survey about management of febrile children without source by primary care physicians
122. The management of febrile infants by primary-care pediatricians in Utah: Comparison with published practice guidelines
123. Special antibacterial problems of the neonate
124. Early identification of sepsis in infants with respiratory distress
125. Antibiotics in neonatal infections
126. Neonatal sepsis
127. A prospective study of nosocomial infection in the neonatal intensive care unit
128. Neonatal septicemia in Riyadh, Saudi Arabia
129. Changing patterns of causative organisms of neonatal septicaemia at the Lagos University Teaching Hospital
130. Neonatal sepsis
131. Neonatal septicemia and perinatal risk factors
132. Neutrophil and band counts in the diagnosis of neonatal infections
133. The hematology of bacterial infections in premature infants
134. Early diagnosis of neonatal sepsis
135. Early diagnosis of neonatal sepsis using a hematologic scoring system
136. Study of the usefulness of clinical and hematologic findings in the diagnosis of neonatal bacterial infections
137. Peripheral leucocyte count and leucocyte indexes in healthy newborn term infants
138. Acute-phase proteins in neonatal infection
139. Identification of infants unlikely to have serious bacterial infection although hospitalised for suspected sepsis
140. Hospitalisation vs outpatient treatment of young febrile infants: 10-Year comparison
141. When to do a lumbar puncture in a neonate
142. A single blood culture for confirmation of the diagnosis of neonatal septicemia
143. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children
144. Presumptive diagnosis of malaria in infants in an endemic area
145. Malaria chemosuppression during pregnancy VI: Some epidemiological aspects of malaria in infants
146. Outpatient treatment of febrile infants 28-89 days of age with intramuscular administration of ceftriaxone
147. Febrile infants: Predictors of bacteremia
148. Outpatient management without antibiotics of fever in selected infants
149. Efficacy of a protocol to distinguish risk of serious bacterial infection in the outpatient evaluation of febrile young infants
150. Observation scales to identify serious illness in febrile children
151. The febrile child and occult bacteremia
152. Relative importance of bacteremia and viremia in the course of acute fevers of unknown origin in outpatient children
153. Patterns of illness in the highly febrile young child: Epidemiologic, clinical, and laboratory correlates
154. Fever in children in the tropics
155. Malaria in early childhood: An investigation of five hundred seriously ill children in whom a 'clinical' diagnosis of malaria was made on admission to the Children's Emergency Room at University College Hospital, Ihadan
156. Criteria for diagnosing clinical malaria among a semi-immune population exposed to intense and perennial transmission
157. Prevalence of bacteriuria in febrile children
158. Childhood infections: Diagnostic value of peripheral white blood cell and differential cell counts
159. Clinical usefulness of polymorphonuclear leukocyte vacuolization in predicting septicemia in febrile children
160. Bacteremia in private pediatric practice
161. Outpatient bacteremia: Clinical findings in children under two years with initial temperatures of 39.5°C or higher
162. Observation, history, and physical examination in diagnosis of serious illnesses in febrile children ≤24 months
163. Bacteremia in febrile children under 2 years of age: Results of cultures of blood of 600 consecutive febrile children seen in a 'walk-in' clinic
164. Bacteremia in febrile children seen in a 'walk-in' pediatric clinic
165. Bacteremia in children: An outpatient clinical review
166. Temperature greater than or equal to 40 C in children less than 24 months of age: A prospective study
167. Management of infants at risk for occult bacteremia: A decision analysis
168. Comparison of acutephase reactants in pediatric patients with fever
169. The erythrocyte sedimentation rate in the newborn period
170. Quantitative C-reactive protein in relation to erythrocyte sedimentation rate, fever, and duration of antimicrobial therapy in bacteraemic diseases of childhood
171. The micro-erythrocyte sedimentation rate as a screening test for bacteraemia in young children with non-focal infections
172. C-reactive protein and zeta sedimentation ratio as indicators of bacteremia in pediatric patients
173. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children
174. Quantitative levels of C-reactive protein in cerebrospinal fluid in patients with bacterial meningitis and other infections
175. The zeta sedimentation ratio
176. The erythrocyte sedimentation rate
177. Serum C-reactive protein levels and falciparum malaria
178. C-reactive protein for rapid monitoring of infections of the central nervous system
179. Comparison of five tests used in diagnosis of neonatal bacteraemia
180. Commentary on practice guidelines
181. Clinical guidelines in the setting of incomplete evidence
182. A revised decision analysis of strategies in the management of febrile children at risk for occult bacteremia
183. Therapy for acute otitis media: Applicability of metaanalysis to the individual patient
184. Should blood cultures be obtained in the evaluation of young febrile children without evident focus of bacterial infection?
185. Strategies for diagnosis and treatment of children at risk for occult bacteremia: Clinical effectiveness and cost-effectiveness
186. Intramuscular versus oral antibiotic therapy for prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia
187. A decline in Haemophilus influenzae type b meningitis
188. Pneumococcal vaccine: Past, present, and future
189. Pneumococcal conjugate vaccines
190. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: An emerging microbial threat
191. Community acquired infections and bacterial resistance
192. Causes of death in sicklecell disease in Jamaica
193. Fluoroquinolones in paediatrics
194. The future of the quinolones